PharmaCyte Biotech Inc (NASDAQ:PMCB)
| 2.88 Delayed Data As of 3:59pm ET |  -0.02 / -0.69%Today’s Change | 1.85 Today|||52-Week Range 3.10 | -1.71% Year-to-Date |
Latest PMCB News | Press Releases
No recent news for PharmaCyte Biotech Inc.
Today’s Trading
| Previous close | 2.90 |
| Today’s open | 2.89 |
| Day’s range | 2.87 - 2.89 |
| Volume | 1,454 |
| Average volume (3 months) | 70,612 |
| Market cap | -- |
Data as of 3:59pm ET, 03/20/2023
Growth & Valuation
| Earnings growth (last year) | +88.90% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
Data as of 3:59pm ET, 03/20/2023
Financials
| Last reporting date | August 22, 2022 |
| EPS forecast (this quarter) | -$0.07 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$4.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Las Vegas, Nevada |
Forecasts
